Exploring Psilocybe cubensis Strains: Cultivation Techniques, Psychoactive Compounds, Genetics and Research Gaps
Open accessThe DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
Abstract
Psilocybe cubensis, a widely recognized psychoactive mushroom species, has played a significant role in both historical and modern therapeutic practices. This review explores the complex interplay between genetic diversity, strain variability and environmental factors that shape the biosynthesis of key psychoactive compounds, including psilocybin and psilocin. With many strains exhibiting substantial variability in their phenotypic characteristics and biochemical content, understanding and documenting this diversity is crucial for optimizing therapeutic applications. The review also highlights advances in cultivation techniques, such as submerged fermentation of the mycelium, and innovative analytical methodologies that have improved the precision of compound quantification and extraction. Although there is limited scientific information on P. cubensis due to nearly four decades of regulatory restrictions on psychedelic research, recent developments in genetic and biochemical studies are beginning to provide valuable insights into its therapeutic potential. Furthermore, this review emphasizes key knowledge gaps and offers insights into future research directions to advance the cultivation, scientific documentation of strain diversity, regulatory considerations and therapeutic use of P. cubensis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![Figure 2 The biosynthetic pathway of psilocybin originates from L-tryptophan, which undergoes decarboxylation, oxygenation and phosphate ester formation to yield norbaeocystin, followed by methylation by the PsiM enzyme. SAM (S-adenosyl-L-methionine) acts as a methyl donor, while SAH (S-adenosyl-L-homocysteine) is the byproduct. A third methyl transfer by PsiM to yield aeruginascin has been proposed. Reprinted from Hudspeth et al. 2024 [33], under a Creative Commons Attribution 4.0 International License.](https://figures.cochat.ai/paper-figures/95d36be7a5f6406f8a2c48a7f7a39793/exploring-psilocybe-cubensis-strains-cultivation-techniques-psychoactive-figure-2.jpg)


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The tryptamine concentration in the “Mak IND” strain is higher than previously reported for other P. cubensis strains [4,11,12].”
From Surprising Variability in Tryptamine Profiles of Psilocybe cubensis Fruiting Bodies: Inter- and Intra-Strain Differences Across 14 Strains Cultivated Under Controlled Conditions (2026) · cites this paper as [4]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Variation in alkaloid production is documented not only across distinct Psilocybe species collected from natural environments but also among strains of the same species maintained under laboratory conditions, particularly in P. cubensis, a species widely cultivated in both domestic and research contexts [4].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nichols, D. E. (2016) · Pharmacological Reviews · doi:10.1124/pr.115.011478 · Cited by 1,762
REBUS and the anarchic brain: Toward a unified model of the brain action of psychedelics
Carhart-Harris, R. L., & Friston, K. J. (2019) · Pharmacological Reviews · doi:10.1124/pr.118.017160 · Cited by 1,180
Bogenschutz, M. P., Ross, S., Bhatt, S., Baron, T., Forcehimes, A. A., Laska, E., Mennenga, S. E., O’Donnell, K., Owens, L. T., Podrebarac, S., et al. (2022) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2022.2096 · Cited by 711 · cited 1×
“Modern research suggests that psychoactive compounds, such as psilocin, have high potential to catalyze therapeutic transformations in treating resistant psychiatric disorders such as depression, anxiety and post-traumatic stress disorder (PTSD) and addiction [5–9].”
Homological scaffolds of brain functional networks
Petri, G., Expert, P., Turkheimer, F., Carhart-Harris, R., Nutt, D., Hellyer, P. J., & Vaccarino, F. (2014) · Journal of The Royal Society Interface · doi:10.1098/rsif.2014.0873 · Cited by 675
Psychedelic drugs: neurobiology and potential for treatment of psychiatric disorders
Vollenweider, F. X., & Preller, K. H. (2020) · Nature Reviews Neuroscience · doi:10.1038/s41583-020-0367-2 · Cited by 570
Single-Dose Psilocybin Treatment for Major Depressive Disorder: A Randomized Clinical Trial
Raison, C. L., Sanacora, G., Woolley, J., Heinzerling, K., Dunlop, B. W., Brown, R. T., Kakar, R., Hassman, M., Trivedi, R. P., Robison, R., et al. (2023) · JAMA · doi:10.1001/jama.2023.14530 · Cited by 545 · cited 1×
“In light of the above, study designs of newer trials have been duly adapted: some use factorial designs [67] of clinical trials to control for expectations and unblinding, while others use active comparators or compare high versus low doses instead of using an inactive placebo, etc. [68,69].”
The subjective effects of psychedelics are necessary for their enduring therapeutic effects
Yaden, D. B., & Griffiths, R. R. (2021) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.0c00194 · Cited by 541 · cited 2×
“Most studies consistently show that the intensity of experience, its positive valence or the ability to achieve mystical experiences are predictors of a long-lasting response [63,64].”
Madsen, M. K., Fisher, P. M., Burmester, D., Dyssegaard, A., Stenbæk, D. S., Kristiansen, S., Johansen, S. S., Lehel, S., Linnet, K., Svarer, C., et al. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-019-0324-9 · Cited by 517
Psychedelics promote neuroplasticity through the activation of intracellular 5-HT2A receptors
Vargas, M. V., Dunlap, L. E., Dong, C., Carter, S. J., Tombari, R. J., Jami, S. A., Cameron, L. P., Patel, S. D., Hennessey, J. J., Saeger, H. N., et al. (2023) · Science · doi:10.1126/science.adf0435 · Cited by 489
The pharmacology of psilocybin
Passie, T., Seifert, J., Schneider, U., & Emrich, H. M. (2002) · Addiction Biology · doi:10.1080/1355621021000005937 · Cited by 465
Psychedelics, mystical experience, and therapeutic efficacy: a systematic review
Ko, K., Knight, G., Rucker, J. J., & Cleare, A. J. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.917199 · Cited by 306 · cited 2×
“Most studies consistently show that the intensity of experience, its positive valence or the ability to achieve mystical experiences are predictors of a long-lasting response [63,64].”
Psilocybin – Summary of knowledge and new perspectives
Tylš, F., Páleníček, T., & Horáček, J. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.12.006 · Cited by 276
Self-citationPsychoplastogens: A promising class of plasticity-promoting neurotherapeutics
Olson, D. E. (2018) · Journal of Experimental Neuroscience · doi:10.1177/1179069518800508 · Cited by 257 · cited 1×
“The second and currently most important mechanism is the enhancement of neuroplasticity at the synaptic level, which is triggered by most psychedelics [74–76].”
The Therapeutic Potential of Psilocybin
Lowe, H., Toyang, N., Steele, B., Valentine, H., Grant, J., Ali, A., Ngwa, W., & Gordon, L. (2021) · Molecules · doi:10.3390/molecules26102948 · Cited by 242
Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms
Inserra, A., De Gregorio, D., & Gobbi, G. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000056 · Cited by 232
Enzymatic Synthesis of Psilocybin
Fricke, J., Blei, F., & Hoffmeister, D. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201705489 · Cited by 200
Psilocybin: from ancient magic to modern medicine
Nichols, D. E. (2020) · The Journal of Antibiotics · doi:10.1038/s41429-020-0311-8 · Cited by 184
Becker, A. M., Holze, F., Grandinetti, T., Klaiber, A., Toedtli, V. E., Kolaczynska, K. E., Duthaler, U., Varghese, N., Eckert, A., Grünblatt, E., et al. (2022) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.2487 · Cited by 184 · cited 1×
“Last but not least, little information exists on concomitant medications—whether psychedelics can be used as add-ons to standard medications or whether and which medications must be tapered off prior to the treatment [65,66].”
Psychedelic Drug Legislative Reform and Legalization in the US
Siegel, J. S., Daily, J. E., Perry, D. A., & Nicol, G. E. (2023) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2022.4101 · Cited by 179
Yao, Y., Guo, D., Lu, T., Liu, F.-L., Huang, S., Diao, M.-Q., Li, S., Zhang, X.-J., Kosten, T. R., Shi, J., et al. (2024) · Psychiatry Research · doi:10.1016/j.psychres.2024.115886 · Cited by 174
Goodwin, G. M., Aaronson, S. T., Alvarez, O., Atli, M., Bennett, J. C., Croal, M., DeBattista, C., Dunlop, B. W., Feifel, D., Hellerstein, D. J., et al. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2023.01.108 · Cited by 173
Self-citationReport of the International Narcotics Control Board for 2020
International Narcotics Control Board (2021) · Report of the International Narcotics Control Board · doi:10.18356/9789210056380 · Cited by 168
Microdosing with psilocybin mushrooms: a double-blind placebo-controlled study
Cavanna, F., Muller, S., de la Fuente, L. A., Zamberlan, F., Palmucci, M., Janeckova, L., Kuchar, M., Pallavicini, C., & Tagliazucchi, E. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-02039-0 · Cited by 134
Molecular Mechanisms of Psilocybin and Implications for the Treatment of Depression
Ling, S., Ceban, F., Lui, L. M. W., Lee, Y., Teopiz, K. M., Rodrigues, N. B., Lipsitz, O., Gill, H., Subramaniapillai, M., Mansur, R. B., et al. (2022) · CNS Drugs · doi:10.1007/s40263-021-00877-y · Cited by 127
Horizontal gene cluster transfer increased hallucinogenic mushroom diversity
Reynolds, H. T., Vijayakumar, V., Gluck-Thaler, E., Korotkin, H. B., Matheny, P. B., & Slot, J. C. (2018) · Evolution Letters · doi:10.1002/evl3.42 · Cited by 111
Mycelium vs. Fruiting Bodies of Edible Fungi—A Comparison of Metabolites
Berger, R. G., Bordewick, S., Krahe, N., & Ersoy, F. (2022) · Microorganisms · doi:10.3390/microorganisms10071379 · Cited by 104
Therapeutic use of psilocybin: Practical considerations for dosing and administration
MacCallum, C. A., Lo, L. A., Pistawka, C. A., & Deol, J. K. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.1040217 · Cited by 102
Rootman, J. M., Kryskow, P., Harvey, K., Stamets, P. E., Santos-Brault, E., Kuypers, K. P. C., Polito, V., Bourzat, F., & Walsh, Z. (2021) · Scientific Reports · doi:10.1038/s41598-021-01811-4 · Cited by 101
Van Court, R. C., Wiseman, M. S., Meyer, K. W., Ballhorn, D. J., Amses, K. R., Slot, J. C., Dentinger, B. T. M., Garibay-Orijel, R., & Uehling, J. K. (2022) · Fungal Biology · doi:10.1016/j.funbio.2022.01.003 · Cited by 94
Drug-drug interactions between psychiatric medications and MDMA or psilocybin: a systematic review
Sarparast, A., Thomas, K., Malcolm, B., & Stauffer, C. S. (2022) · Psychopharmacology · doi:10.1007/s00213-022-06083-y · Cited by 88 · cited 1×
“Last but not least, little information exists on concomitant medications—whether psychedelics can be used as add-ons to standard medications or whether and which medications must be tapered off prior to the treatment [65,66].”
Acute psilocybin enhances cognitive flexibility in rats
Torrado Pacheco, A., Olson, R. J., Garza, G., & Moghaddam, B. (2023) · Neuropsychopharmacology · doi:10.1038/s41386-023-01545-z · Cited by 87
Nkadimeng, S. M., Steinmann, C. M., & Eloff, J. N. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s317182 · Cited by 83
Morphological and chemical analysis of magic mushrooms in Japan
Tsujikawa, K., Kanamori, T., Iwata, Y. T., Ohmae, Y., Sugita, R., Inoue, H., & Kishi, T. (2003) · Forensic Science International · doi:10.1016/j.forsciint.2003.08.009 · Cited by 78
Glue, P., Loo, C. K. A., Fam, J., Lane, H., Young, A. H., Surman, P., BEDROC study investigators, Glozier, N., Fitzgerald, P. B., Liu, D., et al. (2024) · Nature Medicine · doi:10.1038/s41591-024-03063-x · Cited by 78
The therapeutic potential of psilocybin: a systematic review
van Amsterdam, J., & van den Brink, W. (2022) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2022.2047929 · Cited by 74
Effects of Psilocybe argentipes on Marble-Burying Behavior in Mice
MATSUSHIMA, Y., SHIROTA, O., KIKURA-HANAJIRI, R., GODA, Y., & EGUCHI, F. (2009) · Bioscience, Biotechnology, and Biochemistry · doi:10.1271/bbb.90095 · Cited by 71
Conn, K., Milton, L. K., Huang, K., Munguba, H., Ruuska, J., Lemus, M. B., Greaves, E., Homman‐Ludiye, J., Oldfield, B. J., & Foldi, C. J. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02575-9 · Cited by 68
Nkadimeng, S. M., Nabatanzi, A., Steinmann, C. M. L., & Eloff, J. N. (2020) · Plants · doi:10.3390/plants9091127 · Cited by 68
Gotvaldová, K., Hájková, K., Borovička, J., Jurok, R., Cihlářová, P., & Kuchař, M. (2021) · Drug Testing and Analysis · doi:10.1002/dta.2950 · Cited by 67
Sloshower, J., Zeifman, R. J., Guss, J., Krause, R., Safi-Aghdam, H., Pathania, S., Pittman, B., & D’Souza, D. C. (2024) · Scientific Reports · doi:10.1038/s41598-024-58318-x · Cited by 65
Zhuk, O., Jasicka-Misiak, I., Poliwoda, A., Kazakova, A., Godovan, V., Halama, M., & Wieczorek, P. (2015) · Toxins · doi:10.3390/toxins7041018 · Cited by 62
Extraction and analysis of indole derivatives from fungal biomass
Gartz, J. (1994) · Journal of Basic Microbiology · doi:10.1002/jobm.3620340104 · Cited by 58
Laussmann, T., & Meier-Giebing, S. (2010) · Forensic Science International · doi:10.1016/j.forsciint.2009.12.013 · Cited by 56
Singer, R., & Smith, A. H. (1958) · Mycologia · doi:10.2307/3756197 · Cited by 56
Extensive Collection of Psychotropic Mushrooms with Determination of Their Tryptamine Alkaloids
Gotvaldová, K., Borovička, J., Hájková, K., Cihlářová, P., Rockefeller, A., & Kuchař, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232214068 · Cited by 53 · cited 2×
“Although Table 1 focuses exclusively on P. cubensis , we note that Gotvaldová et al. [14] conducted a study focused on other Psilocybe species and more, analyzing the biochemical diversity of 226 fruiting bodies collected from diverse geographical regions.”
Keller, T., Schneider, A., Regenscheit, P., Dirnhofer, R., Rücker, T., Jaspers, J., & Kisser, W. (1999) · Forensic Science International · doi:10.1016/s0379-0738(98)00168-6 · Cited by 51
Biocatalytic Production of Psilocybin and Derivatives in Tryptophan Synthase‐Enhanced Reactions
Blei, F., Baldeweg, F., Fricke, J., & Hoffmeister, D. (2018) · Chemistry – A European Journal · doi:10.1002/chem.201801047 · Cited by 51
Magaraggia, I., Kuiperes, Z., & Schreiber, R. (2021) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2021.107467 · Cited by 49
Borner, S., & Brenneisen, R. (1987) · Journal of Chromatography A · doi:10.1016/s0021-9673(01)81831-8 · Cited by 47
Anastos, N., Lewis, S. W., Barnett, N. W., & Sims, D. N. (2006) · Journal of Forensic Sciences · doi:10.1111/j.1556-4029.2005.00033.x · Cited by 44
Bradshaw, A. J., Ramírez-Cruz, V., Awan, A. R., Furci, G., Guzmán‐Dávalos, L., Stamets, P. E., & Dentinger, B. T. M. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2311245121 · Cited by 44
Acute Effects of the Novel Psychoactive Drug 2C-B on Emotions
González, D., Torrens, M., & Farré, M. (2015) · BioMed Research International · doi:10.1155/2015/643878 · Cited by 43
Bigwood, J., & Beug, M. W. (1982) · Journal of Ethnopharmacology · doi:10.1016/0378-8741(82)90014-9 · Cited by 42
Shahar, O., Botvinnik, A., Shwartz, A., Lerer, E., Golding, P., Buko, A., Hamid, E., Kahn, D., Guralnick, M., Blakolmer, K., et al. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02477-w · Cited by 40 · cited 2×
“Further research is needed to confirm these observations and identify the specific molecules responsible for the enhanced effects of natural extracts [35].”
Wurst, M., Semerdžieva, M., & Vokoun, J. (1984) · Journal of Chromatography A · doi:10.1016/s0021-9673(01)99190-3 · Cited by 39
Genetic Survey of Psilocybe Natural Products
Dörner, S., Rogge, K., Fricke, J., Schäfer, T., Wurlitzer, J. M., Gressler, M., Pham, D. N. K., Manke, D. R., Chadeayne, A. R., & Hoffmeister, D. (2022) · ChemBioChem · doi:10.1002/cbic.202200249 · Cited by 39
Goff, R., Smith, M., Islam, S., Sisley, S., Ferguson, J., Kuzdzal, S., Badal, S., Kumar, A. B., Sreenivasan, U., & Schug, K. A. (2024) · Analytica Chimica Acta · doi:10.1016/j.aca.2023.342161 · Cited by 36
Saito, K., Toyo’oka, T., Kato, M., Fukushima, T., Shirota, O., & Goda, Y. (2005) · Talanta · doi:10.1016/j.talanta.2004.11.031 · Cited by 34
The therapeutic potential of psychedelics: the European regulatory perspective
Butlen‐Ducuing, F., McCulloch, D. E.-W., Haberkamp, M., Mattila, T., Bałkowiec-Iskra, E., Aislaitner, G., Balabanov, P., Lundberg, J., Stenbæk, D. S., Elferink, A. J. A., et al. (2023) · The Lancet · doi:10.1016/s0140-6736(23)00264-7 · Cited by 33
Nkadimeng, S. M., Steinmann, C. M. L., & Eloff, J. N. (2020) · Scientific Reports · doi:10.1038/s41598-020-79328-5 · Cited by 32
Meade, E., Hehir, S., Rowan, N. J., & Garvey, M. (2022) · Journal of Fungi · doi:10.3390/jof8030290 · Cited by 32
Methyl transfer in psilocybin biosynthesis
Hudspeth, J. D., Rogge, K., Dörner, S., Müll, M., Hoffmeister, D., Rupp, B., & Werten, S. (2024) · Nature Communications · doi:10.1038/s41467-024-46997-z · Cited by 31
Bradshaw, A. J., Backman, T. A., Ramírez-Cruz, V., Forrister, D. L., Winter, J. M., Guzmán-Dávalos, L., Furci, G., Stamets, P., & Dentinger, B. T. M. (2022) · Applied and Environmental Microbiology · doi:10.1128/aem.01498-22 · Cited by 29
Gasser, P. (2021) · Current topics in behavioral neurosciences · doi:10.1007/7854_2021_268 · Cited by 29
Plant Medicines, Healing and Psychedelic Science
(2018) · Springer eBooks · doi:10.1007/978-3-319-76720-8 · Cited by 29
de la Salle, S., Kettner, H., Lévesque, J. T., Garel, N., Dames, S., Patchett-Marble, R., Rej, S., Gloeckler, S. G., Erritzøe, D., Carhart-Harris, R. L., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-66817-0 · Cited by 29
Determination of psilocybin in Psilocybe semilanceata by capillary zone electrophoresis
Pedersen‐Bjergaard, S., Sannes, E., Rasmussen, K. E., & Tønnesen, F. (1997) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/s0378-4347(97)00127-8 · Cited by 28
Exploring the regulatory framework of psychedelics in the US & Europe
Behera, H. K., Joga, R., Yerram, S., Karnati, P., Mergu, T., Gandhi, K., Sowndharya, M., Nathiya, D., Singh, R. P., Srivastava, S., et al. (2024) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2024.104242 · Cited by 28
S‐Adenosyl‐ l ‐Methionine Salvage Impacts Psilocybin Formation in “Magic” Mushrooms
Demmler, R., Fricke, J., Dörner, S., Gressler, M., & Hoffmeister, D. (2019) · ChemBioChem · doi:10.1002/cbic.201900649 · Cited by 27
Andrews, C. M., Hall, W., Humphreys, K. N., & Marsden, J. (2024) · Addiction · doi:10.1111/add.16575 · Cited by 27
The production of psilocybin in submerged culture by Psilocybe cubensis.
Catalfomo, P., & Tyler, V. E. (1964) · Lloydia · Cited by 26
Magic truffles or Philosopher's stones: a legal way to sell psilocybin?
Pellegrini, M., Rotolo, M. C., Marchei, E., Pacifici, R., Saggio, F., & Pichini, S. (2012) · Drug Testing and Analysis · doi:10.1002/dta.1400 · Cited by 25
Colla, M., Offenhammer, B., Scheerer, H., Kronenberg, G., Vetter, S., Mutschler, J., Mikoteit, T., Bankwitz, A., Adank, A., Schaekel, L., et al. (2024) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2024.03.002 · Cited by 23
Cipriani, A., & Barbui, C. (2013) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796013000231 · Cited by 22
Analysis and Cultivation of Fruit Bodies and Mycelia of Psilocybe bohemica
Gartz, J., & Moller, G. K. (1989) · Biochemie und Physiologie der Pflanzen · doi:10.1016/s0015-3796(89)80023-x · Cited by 20
Polo-Castellano, C., Álvarez, J. Á., Palma, M., Barbero, G. F., Ayuso, J., & Ferreiro-González, M. (2022) · Journal of Fungi · doi:10.3390/jof8060598 · Cited by 20
Singer, R., & Smith, A. H. (1958) · Mycologia · doi:10.1080/00275514.1958.12024726 · Cited by 19
Gambaro, V., Roda, G., Visconti, G. L., Arnoldi, S., Casagni, E., Dell’Acqua, L., Farè, F., Paladino, E., Rusconi, C., Arioli, S., et al. (2016) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2016.03.043 · Cited by 18
Biotechnology of Mushroom Growth Through Submerged Cultivation
Petre, M., & Petre, V. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802794-3.00001-1 · Cited by 18
Strauss, D., Ghosh, S. B., Murray, Z., & Gryzenhout, M. (2022) · 3 Biotech · doi:10.1007/s13205-022-03355-4 · Cited by 18
A draft reference assembly of the Psilocybe cubensis genome
McKernan, K. J., Kane, L. T., Crawford, S. S., Chin, C.-S., Trippe, A., & McLaughlin, S. (2021) · F1000Research · doi:10.12688/f1000research.51613.2 · Cited by 16
Exploring Psilocybe spp. mycelium and fruiting body chemistry for potential therapeutic compounds
Waldbillig, A., Baranova, M., Neumann, S., Andrade, J., & Sidhu, S. (2023) · Frontiers in Fungal Biology · doi:10.3389/ffunb.2023.1295223 · Cited by 13
A whole genome atlas of 81 Psilocybe genomes as a resource for psilocybin production.
McKernan, K. J., Kane, L. T., Helbert, Y., Zhang, L., Houde, N., & McLaughlin, S. (2021) · F1000Research · doi:10.12688/f1000research.55301.1 · Cited by 13
McTaggart, A. R., James, T. Y., Slot, J. C., Barlow, C., Fechner, N., Shuey, L. S., & Drenth, A. (2022) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2022.103769 · Cited by 13
Neal, J. M., BENEDICT, R. G., & Brady, L. R. (1968) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600571006 · Cited by 12
Genetic regulation of l-tryptophan metabolism in Psilocybe mexicana supports psilocybin biosynthesis
Seibold, P. S., Dörner, S., Fricke, J., Schäfer, T., Beemelmanns, C., & Hoffmeister, D. (2024) · Fungal Biology and Biotechnology · doi:10.1186/s40694-024-00173-6 · Cited by 12
Kryskow, P., Stamets, P. E., Torre, J. T. L., Sattler, K., Tsang, V. W. L., & Williams, M. T. (2024) · Journal of Psychedelic Studies · doi:10.1556/2054.2024.00379 · Cited by 12
Xi, D., Berger, A., Shurtleff, D., Zia, F. Z., & Belouin, S. J. (2023) · Neuropharmacology · doi:10.1016/j.neuropharm.2023.109467 · Cited by 11
Běláčková, V., Rychert, M., Wilkins, C., & Pardal, M. (2023) · Clinical Therapeutics · doi:10.1016/j.clinthera.2023.03.017 · Cited by 11
The Influence of Humidity Upon Transpiration and Growth inPsilocybe Cubensis
Badham, E. R. (1985) · Mycologia · doi:10.1080/00275514.1985.12025182 · Cited by 10
Substrate recognition by the 4‐hydroxytryptamine kinase PsiK in psilocybin biosynthesis
Rogge, K., Wagner, T. J., Hoffmeister, D., Rupp, B., & Werten, S. (2024) · FEBS Letters · doi:10.1002/1873-3468.15042 · Cited by 6
Agurell, S., Blomkvist, S., & Catalfomo, P. (1966) · PubMed · Cited by 4
Vella, Y., Syrová, K., Petrušková, A., Koutrouli, I. R. A., Kútna, V., Pala, J., Nikolič, M., Šíchová, K., Mazoch, V., Jurok, R., et al. (2025) · Journal of Psychopharmacology · doi:10.1177/02698811251338232 · Cited by 3
Self-citationSystematic Review on the Mechanisms of Action of Psilocybin in the Treatment of Depression
Lin, M. C., Lee, H., Tsang, V. W. L., Chai, B., Howard, A., Uy, C., & Elefante, J. (2023) · PubMed Central · doi:10.1192/j.eurpsy.2023.898 · Cited by 3
(2024) · JAMA · doi:10.1001/jama.2024.0828 · Cited by 2
Nkadimeng, S. M., Hay, L., Steinmann, C. M. L., & Eloff, J. N. (2023) · Research Square · doi:10.21203/rs.3.rs-3088850/v1 · Cited by 1
Vella, Y., Syrová, K., Petrušková, A., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.08.07.606965 · Cited by 1
A whole genome atlas of 81 Psilocybe genomes as a resource for psilocybin production.
McKernan, K. J., Kane, L. T., Helbert, Y., Zhang, L., Houde, N., & McLaughlin, S. (2021) · F1000Research · doi:10.12688/f1000research.55301.2
Research works printed but not linked: 6
- (2024, December 01). PubMed: A Database of Biomedical Literature, Available online: https://pubmed.ncbi.nlm.nih.gov/.
- Mandrake, K., and Haze, V. (2016). The Psilocybin Mushroom Bible: The Definitive Guide to Growing and Using Magic Mushrooms, Green Candy Press.
- Stijve, 1993, Macromycetes from the state of Paraná, Brazil. 4. The psychoactive species, Braz. Arch. Biol. Technol., 36, 313
- (2024, December 01). GenBank: Genetic Sequence Database of the National Institutes of Health, Available online: https://www.ncbi.nlm.nih.gov/genbank/.
- Kurzbaum, E., Azerrad, S., Rosenberg, A., Lewinsohn, D., and Dekel, Y. (2024, January 24–27). Enhancing the Bioactive Components in Psilocybe cubensis Mycelium: The Influence of Submerged Fermentation Conditions [Abstract]. Proceedings of the 12th International Medicinal Mushrooms Conference, Bari, Italy.
- (2024, December 01). EMA Multistakeholder Workshop on Psychedelics: Workshop Report, 16–17 April 2024. European Medicines Agency. Available online: https://www.euda.europa.eu/event/2024/04/ema-multi-stakeholder-workshop-psychedelics-towards-eu-regulatory-framework_en.
Cited by
Global mushroom market: Bioactive compounds of major species and biotechnology applications
Tavares, Y. V., Contato, A. G., & Conte-Junior, C. A. (2025) · Journal of Future Foods · doi:10.1016/j.jfutfo.2025.11.010 · Cited by 11
Murray, Z., Lewies, A., Wentzel, J. F., Schutte‐Smith, M., Erasmus, E., Noreljaleel, A. E. M., Visser, H. G., Wilhelm, A., & Issahaku, A. R. (2026) · Scientific Reports · doi:10.1038/s41598-026-39483-7 · Cited by 7
Novel qNMR Method to Quantify Psilocybin and Psilocin in Psychedelic Mushrooms
Rodríguez, L. C., Morera, G., Lupo, S., Davyt, D., Carrera, I., & Dossi, G. H. (2025) · ACS Omega · doi:10.1021/acsomega.5c07092 · Cited by 3
Gandía, A., & Christiansen, S. L. M. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.04.21.649716 · Cited by 2
Sharchaton, A., Parsha, S., Azerrad, S. P., Dekel, Y., Rabah, N., Páleníček, T., & Kurzbaum, E. (2026) · Journal of Fungi · doi:10.3390/jof12070486 · Cited by 1
Self-citation
Metadata
- Authors
- Kurzbaum, E., Páleníček, T., Sharchaton, A., Azerrad, S., & Dekel, Y.
- Affiliations
- Tel Hai Academic College (IL)
- Charles University (CZ)
- University of Haifa (IL)
- Corresponding author
- Kurzbaum, Eyal
- Venue
- Journal of Fungi
- Publisher
- MDPI AG
- Published
- 2025-01-28
- Volume
- 11
- Issue
- 2
- Pages
- 99
- ISSN
- 2309-608X (ISSN-L)
- PMC
- PMC11856550
- OpenAlex
- W4406904437
- Cited by
- 15
- References
- 95
- Citations by year
- 2026: 8 · 2025: 7
- FWCI
- 3.30
- Type
- journal article
- Language
- en
- Update notices
- correction (2025-01-28)
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of Fungi (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Israeli Ministry of Innovation, Science and Technology (1001802444)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
- Health Sciences › Medicine › Pharmacology (medical) › Fungal Biology and Applications
- Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Microbial Natural Products and Biosynthesis
- Keywords
- Psilocybe cubensis, psilocybin, psilocin, psychedelic mushrooms, strain differences, genetic diversity, submerged fermentation, psychedelic therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.